Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

QTTB stock hub

Q32 Bio Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

QTTBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

91.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

QTTB

In the news

Latest news · QTTB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E2.1

P25 14.9P50 23.2P75 38.5

ROE157.2

P25 -105.6P50 -46.5P75 -3.1

ROIC35.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All QTTB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661998
Company name	Q32 Bio Inc.
Country	United States
Country code	US
Cusip	746964105
Employees	24
Employees Change	-19%
Employees Change Percent	-44.19
Enterprise value	$54M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US7469641051
Last refreshed	2026-05-10
Market cap	$91.1M
Market cap category	Micro-Cap
Price	$5.37
Price currency	USD
Rev Per Employee	2,239,041.67x
Sector	Healthcare
Sic	2834
Symbol	QTTB
Website	https://www.q32bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	36.51%
EV Earnings	1.62x
EV/EBIT	2.52x
EV/EBITDA	2.48x
EV/Sales	1x
FCF yield	-30.1%
P/B ratio	1.7x
P/E ratio	2.07x
P/S ratio	1.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.84%
EBITDA Margin	40.51%
Gross margin	71.62%
Gross Profit	$38.5M
Net Income	$33.2M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	61.86%
Profit Margin	61.86%
Profit Per Employee	$1.4M
Profitable Years	1
ROA	18.75
ROCE	40.39
ROE	157.2
ROIC	35.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	242.33%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.75
Assets	$63.7M
Cash	$50.8M
Current Assets	$57.2M
Current Liabilities	$10.7M
Debt	$13.6M
Debt EBITDA	$0.58
Debt Equity	$0.29
Equity	$46.3M
Interest Coverage	21.41
Liabilities	$17.4M
Long Term Assets	$6.5M
Long Term Liabilities	$6.7M
Net Cash	$37.1M
Net Cash By Market Cap	$40.75
Net Cash Growth	-20.52%
Net Debt EBITDA	$-1.7
Net Debt Equity	$-0.8
Tangible Book Value	$46.3M
Tangible Book Value Per Share	$3.17
WACC	-1.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.36
Net Working Capital	$2.7M
Quick ratio	4.81
Working Capital	$46.5M
Working Capital Turnover	$1.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.51%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	242.04%
200-day SMA	3.58
50-day SMA	5.89
50-day SMA vs 200-day SMA	50over200
All Time High	53.79
All Time High Change	-90.02%
All Time High Date	2024-09-11
All Time Low	1.35
All Time Low Change	299.26%
All Time Low Date	2025-07-07
ATR	0.59
Beta	-1.27
Beta1y	-1.26
Beta2y	0.37
Ch YTD	61.75
High	5.47
High52	8.05
High52 Date	2026-03-27
High52ch	-33.25%
Low	5.27
Low52	1.35
Low52 Date	2025-07-07
Low52ch	299.26%
Ma50ch	-8.81%
Premarket Change Percent	-0.74
Premarket Price	$5.4
Premarket Volume	1,205
Price vs 200-day SMA	50.08%
RSI	45.71
RSI Monthly	46.21
RSI Weekly	54.53
Sharpe ratio	1.33x
Sortino ratio	3.34
Total Return	-5.51%
Tr YTD	61.75
Tr1m	-8.98%
Tr1w	6.55%
Tr3m	26.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.65
Operating Income	$21.4M
Operating margin	39.84
Price target	$13
Price Target Change	$142

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,403,253%
Float Percent	37.76%
Net Borrowing	-4,688,000
Shares Insiders	0.71%
Shares Institutions	13.29%
Shares Out	16,956,415
Shares Qo Q	11.93%
Shares Yo Y	5.51%
Short Float	5.97%
Short Ratio	1.15
Short Shares	2.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-32.9M
Average Volume	315,647.75x
Bv Per Share	3.17
Ch1m	-8.98
Ch1w	6.55
Ch1y	242
Ch3m	26.65
Ch6m	137.6
Change	-1.29%
Change From Open	0
Close	5.44
Days Gap	-1.29
Depreciation Amortization	362,000
Dollar Volume	611,782.6
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$21.4M
EBITDA	$21.8M
EPS	$2.59
F Score	4
FCF	$-27.4M
FCF EV Yield	-50.79x
FCF Per Share	$-1.62
Financing CF	5,672,000
Fiscal Year End	December
Founded	2,015
Graham Number	13.59541
Graham Upside	153.2
Investing CF	7,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	4.14
Ma150ch	29.68%
Ma20	5.76
Ma20ch	-6.74%
Net CF	-14,732,000
Next Earnings Date	2026-08-05
Open	5.37
Optionable	No
Position In Range	50
Post Close	5.37
Postmarket Change Percent	1.3
Postmarket Price	$5.44
Ppne	5,826,000
Pre Close	5.44
Price Date	2026-05-08
Price EBITDA	$4.18
Ptbv Ratio	1.97
Relative Volume	0.36x
Revenue	53,737,000x
SBC By Revenue	10.16x
Share Based Comp	5,461,000
Tr6m	137.61%
Us State	Massachusetts
Volume	113,926
Z Score	-0.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does QTTB pay a dividend?

Capital-return profile for this ticker.

Performance

QTTB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns QTTB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.3%

Float: +37.8% of shares outstanding

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

QTTB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.7

Neutral momentum band

Price vs 200-day MA

+50.1%

50/200-day relationship not available

Beta (5Y)

-1.27

Less volatile than the market

Sharpe ratio

1.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About QTTB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current QTTB stock rating?

Q32 Bio Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full QTTB analysis?

The full report lives at /stocks/QTTB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for QTTB?

The latest report frames QTTB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the QTTB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.